| BSE: 532482 | Sector: Health care |
| NSE: GRANULES | ISIN Code: INE101D01020 |
| BSE 12:13 | 24 Jan | 94.30 |
1.10 (1.18%) |
OPEN
94.25 |
HIGH
96.50 |
LOW
93.55 |
| NSE 12:04 | 24 Jan | 94.25 |
0.95 (1.02%) |
OPEN
94.70 |
HIGH
96.60 |
LOW
93.35 |
| OPEN | 94.25 |
| PREVIOUS CLOSE | 93.20 |
| VOLUME | 183513 |
| 52-Week high | 141.55 |
| 52-Week low | 71.75 |
| P/E | 16.15 |
| Mkt Cap.(Rs cr) | 2,397 |
| Buy Price | 94.20 |
| Buy Qty | 122.00 |
| Sell Price | 94.30 |
| Sell Qty | 260.00 |
Incorporated as a private limited company in 1991, Granules India (GIL) was converted into a public limited company in Feb.'93. It commenced its operations in Apr.'91 as a merchant exporter of bulk drugs like paracetamol, guaifenesin and chloro pheniramine maleate. The company exports to the US, Europe, Mexico and Hongkong. Since 1992, GIL concentrated on export of paracetamol powder. In Aug.'...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
2,397 | |
| EPS - TTM | () |
[*S] | 5.84 |
| P/E Ratio | (X) | [*S] | 16.15 |
| Face Value | () |
1 | |
| Latest Dividend | (%) | 25.00 | |
| Latest Dividend Date | 06 Nov 2018 | ||
| Dividend Yield | (%) | 1.07 | |
| Book Value / Share | () |
[*S] | 52.26 |
| P/B Ratio | () |
[*S] | 1.80 |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for The Un-Audited Financial Results For The Third Quarter Ended December 3
Granules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
Statement Of Investor Complaints For The Quarter Ended December 2018
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 580.87 | 392.56 | 47.97 |
| Other Income | 17.21 | 11.69 | 47.22 |
| Total Income | 598.08 | 404.25 | 47.95 |
| Total Expenses | 480.34 | 315.65 | 52.17 |
| Operating Profit | 117.74 | 88.6 | 32.89 |
| Net Profit | 60.26 | 40.34 | 49.38 |
| Equity Capital | 25.42 | 25.38 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| FDC | 165.70 | -0.06 | 2889.81 |
| Suven Life Scie. | 200.35 | -1.84 | 2550.46 |
| J B Chem & Pharm | 317.10 | -0.61 | 2544.73 |
| Granules India | 94.30 | 1.18 | 2397.11 |
| Sequent Scien. | 81.45 | -1.57 | 1985.34 |
| Indoco Remedies | 202.20 | -3.04 | 1863.27 |
| Hikal | 151.10 | -0.85 | 1863.06 |
|
|
|
| Date | Broker | Action | Price | Report |
| 12/11 | Equirus Securities | Overweight | 127 |  Details |
| 17/08 | HDFC Securities | Buy | 127 | Details |
| 08/02 | Nirmal Bang | Hold | 129 | Details |
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 4.72% | 4.49% | -0.65% | -0.69% |
| 1 Month | 6.61% | 6.50% | 1.88% | 1.56% |
| 3 Month | 2.33% | 2.11% | 6.18% | 5.92% |
| 6 Month | 2.84% | 2.95% | -1.87% | -2.73% |
| 1 Year | -32.64% | -32.68% | -0.07% | -2.31% |
| 3 Year | -21.29% | -21.39% | 47.89% | 45.91% |
| Today's Low/High | 93.55 |
|
96.50 |
| Week Low/High | 85.30 |
|
96.50 |
| Month Low/High | 85.10 |
|
96.50 |
| YEAR Low/High | 71.75 |
|
142.00 |
| All TIME Low/High | 1.58 |
|
164.00 |
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other